Join us in Vienna for an insightful event where we will cover key topics such as navigating FDA changes, preparing for post-IRA strategies, leveraging new patent policies, understanding market shifts in life sciences, adapting to AI and deep tech deregulation, and avoiding supply chain disruptions from geopolitical effects. Our esteemed speaker, Chia-Feng Lu, shareholder at the US law firm Greenberg Traurig with unparalleled expertise in regulatory and transactional law for life sciences and emerging technologies, will share his invaluable insights on what the bioindustry can expect from the new Trump administration. This is a unique opportunity to gain critical knowledge and network with industry leaders.
We look forward to seeing you there!
Organized by Golden Gate to Europe